Rating History for Rocket Pharmaceuticals (RCKT) by Chardan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/1/2026 | Keay Nakae | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.72 (3.74) |
0.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/1/2026 | Keay Nakae | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.72 (3.74) |
0.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||